Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Cash Flows [Abstract]
Net income (loss)	$ (50,403)	$ 59,073	$ 39,745
Adjustments to reconcile net income (loss) to net cash used in (provided by) operating activities:
Provision for (recovery of) bad debts	(467)	595	(3,986)
Deferred tax (benefit) expense	(10,102)	(2,739)	22,322
Depreciation and amortization	25,946	27,474	27,316
Amortization of debt discount and issuance costs	15,036	3,366	3,968
Interest paid-in-kind	0	3,421	2,832
Equity-based compensation	13,757	4,809	799
Contingent consideration	2,696	26,441	640
Warranty provision	516	953	1,387
Provision for inventory obsolescence	990	1,225	1,742
Changes in operating assets and liabilities
Accounts receivable	(116,848)	(23,038)	(40,708)
Inventories	(88,184)	28,340	(94,594)
Income tax receivables	8,106	(16,530)	9,941
Prepaid expenses and other	(21,226)	1,101	2,228
Accounts payable	8,637	(50,519)	105,481
Accounts payable - related party	(1,622)	0	0
Accrued expenses and other	9,133	10,913	(1,978)
Income tax payable	(8,754)	6,870	1,944
Lease liabilities	221	0	0
Contingent consideration	0	(25,000)	0
Deferred revenue	(50,619)	(178,960)	306,994
Net cash provided by (used in) operating activities	(263,187)	(122,205)	386,073
Cash flows used in investing activities
Purchase of property, plant and equipment	(3,357)	(1,338)	(1,697)
Investment in equity security	(11,975)	0	0
Net cash used in investing activities	(15,332)	(1,338)	(1,697)
Cash flows from financing activities
Proceeds from issuance of convertible notes	413,321	0	0
Premium paid on capped call	(52,870)	0	0
Fees paid on issuance of convertible notes	(1,591)	0	0
Dividends paid on Series A Preferred	(8,051)	0	0
Proceeds from Series A issuance	224,987	0	0
Proceeds from common stock issuance	120,645	0	0
Series A equity issuance costs	(7,195)	0	0
Common stock issuance costs	(3,873)	0	0
Proceeds from revolving credit facility	126,033	0	0
Payments on revolving credit facility	(126,033)	0	0
Principal payments on term loan	0	(57,702)	(25,000)
Proceeds from term loan facility	0	575,000	0
Principal payments on term loan facility	(133,225)	(115,000)	0
Proceeds from (Payments on) revolving loan	0	(70)	(39,078)
Payments on related party loans	0	(45,558)	0
Payment of special distribution	0	(589,000)	0
Proceeds from issuance of common stock, net of underwriting discount and commissions	0	145,532	0
Contingent consideration	(7,810)	0	0
Deferred offering costs	0	(6,464)	0
Debt issuance costs	(6,590)	(36,011)	0
Capital contribution	0	0	133
Net cash provided by (used in) financing activities	537,748	(129,273)	(63,945)
Net change in cash and cash equivalents	259,229	(252,816)	320,431
Cash and cash equivalents, beginning of period	108,441	361,257	40,826
Cash and cash equivalents, end of period	367,670	108,441	361,257
Supplemental Cash Flow Information
Cash paid for interest	24,306	6,935	11,343
Cash paid for income taxes	$ 13,318	$ 31,103	$ 443